Literature DB >> 24809760

Osteoporosis and fractures after solid organ transplantation: a nationwide population-based cohort study.

Tung-Min Yu1, Cheng-Li Lin2, Shih-Ni Chang2, Fung-Chang Sung3, Shih-Ting Huang1, Chia-Hung Kao4.   

Abstract

OBJECTIVE: To investigate the incidence of bone disorders after solid organ transplantation (SOT). PARTICIPANTS AND METHODS: We used Taiwan's National Health Insurance Research Database to identify 9428 recipients of SOT and 38,140 sex- and age- matched control subjects between January 1, 1997, and December 31, 2010, to compare the incidence and risk of bone disorders between groups.
RESULTS: Recipients of SOT had a significantly higher incidence of osteoporosis and related fractures compared with the non-SOT group. The overall hazard ratio (HR) of osteoporosis after SOT was 5.14 (95% CI, 3.13-8.43), and the HR of related fractures was 5.76 (95% CI, 3.80-8.74). The highest HRs were observed in male patients (HR, 7.09; 95% CI, 3.09-16.3) and in those aged 50 years or younger (HR, 7.38; 95% CI, 2.46-22.1). In addition, SOT patients without any comorbidities had a 9.03-fold higher risk of osteoporosis than non-SOT participants (HR, 9.03; 95% CI, 5.29-15.4). To compare the risk of osteoporosis and related fractures in different recipients of SOT, the highest risk of osteoporosis and fractures was noted in patients receiving lung transplantation, followed by other types of SOT.
CONCLUSION: We report high rates of metabolic bone disorders after SOT in chronic transplant patients over a long follow-up. Both underlying bone disorders before transplantation and use of immunosuppressant agents may contribute to bone disorders after transplantation.
Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24809760     DOI: 10.1016/j.mayocp.2014.02.017

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  12 in total

Review 1.  Osteoporosis in the adult solid organ transplant population: underlying mechanisms and available treatment options.

Authors:  C Early; L Stuckey; S Tischer
Journal:  Osteoporos Int       Date:  2015-10-16       Impact factor: 4.507

Review 2.  CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health.

Authors:  A Prytuła; K Cransberg; A Raes
Journal:  Pharmacogenomics J       Date:  2017-04-18       Impact factor: 3.550

3.  Post-operative medical and surgical complications after primary total joint arthroplasty in solid organ transplant recipients: a case series.

Authors:  Andrew C Palmisano; Andrew W Kuhn; Andrew G Urquhart; Aidin Eslam Pour
Journal:  Int Orthop       Date:  2016-08-06       Impact factor: 3.075

4.  Risk factors associated with end-stage renal disease (ESRD) in patients with atherosclerotic renal artery stenosis: a nationwide population-based analysis.

Authors:  Tung-Min Yu; Chung-Shu Sun; Cheng-Li Lin; Chen-Yu Wang; Pi-Yi Chang; Che-Yi Chou; Ya-Wen Chuang; Bor-Jen Lee; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 5.  Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.

Authors:  Gong-bin Lan; Xu-biao Xie; Long-kai Peng; Lei Liu; Lei Song; He-long Dai
Journal:  Biomed Res Int       Date:  2015-11-15       Impact factor: 3.411

6.  Systemic Administration of Allogeneic Mesenchymal Stem Cells Does Not Halt Osteoporotic Bone Loss in Ovariectomized Rats.

Authors:  Shuo Huang; Liangliang Xu; Yuxin Sun; Sien Lin; Weidong Gu; Yamei Liu; Jinfang Zhang; Lin Chen; Gang Li
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

7.  Myostatin and other musculoskeletal markers in lung transplant recipients.

Authors:  Katharina Kerschan-Schindl; Gerold Ebenbichler; Wolfgang Gruther; Ursula Föger-Samwald; Stefan Kudlacek; Janina Patsch; Andreas Gleiss; Peter Jaksch; Walter Klepetko; Peter Pietschmann
Journal:  Clin Exp Med       Date:  2018-10-13       Impact factor: 3.984

Review 8.  Bone Diseases in Patients with Chronic Liver Disease.

Authors:  Hae Min Jeong; Dong Joon Kim
Journal:  Int J Mol Sci       Date:  2019-08-31       Impact factor: 5.923

9.  [Osteoporosis in pneumological diseases : Joint guideline of the Austrian Society for Bone and Mineral Research (ÖGKM) and the Austrian Society for Pneumology (ÖGP)].

Authors:  Christian Muschitz; Ralf Harun Zwick; Judith Haschka; Hans Peter Dimai; Martina Rauner; Karin Amrein; Robert Wakolbinger; Peter Jaksch; Ernst Eber; Peter Pietschmann
Journal:  Wien Klin Wochenschr       Date:  2021-06-16       Impact factor: 1.704

10.  Tacrolimus-induced hypomagnesemia and hypercalciuria requires FKBP12 suggesting a role for calcineurin.

Authors:  Brittany D K Gratreak; Elizabeth A Swanson; Rebecca A Lazelle; Sabina K Jelen; Joost Hoenderop; René J Bindels; Chao-Ling Yang; David H Ellison
Journal:  Physiol Rep       Date:  2020-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.